Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Device Removal | 5 | 2023 | 630 | 1.010 |
Why?
|
Angiography | 3 | 2020 | 1595 | 0.740 |
Why?
|
Vena Cava Filters | 3 | 2021 | 261 | 0.650 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 8 | 2008 | 305 | 0.590 |
Why?
|
Pulmonary Artery | 3 | 2024 | 1927 | 0.560 |
Why?
|
Foreign Bodies | 1 | 2019 | 402 | 0.480 |
Why?
|
Yttrium Radioisotopes | 1 | 2015 | 107 | 0.470 |
Why?
|
Embolization, Therapeutic | 4 | 2024 | 1418 | 0.460 |
Why?
|
Male Urogenital Diseases | 1 | 2014 | 48 | 0.460 |
Why?
|
Pulmonary Embolism | 5 | 2021 | 2567 | 0.440 |
Why?
|
Magnetic Resonance Angiography | 4 | 2021 | 1432 | 0.440 |
Why?
|
Aortic Aneurysm, Abdominal | 5 | 2023 | 1228 | 0.440 |
Why?
|
Catheterization, Peripheral | 1 | 2016 | 343 | 0.420 |
Why?
|
Ultrasonography, Interventional | 2 | 2023 | 1496 | 0.400 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1121 | 0.390 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2009 | 619 | 0.370 |
Why?
|
Liver Neoplasms | 5 | 2020 | 4319 | 0.340 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 2024 | 141 | 0.340 |
Why?
|
Pelvis | 1 | 2014 | 733 | 0.330 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1273 | 0.320 |
Why?
|
Arteriovenous Malformations | 2 | 2024 | 396 | 0.310 |
Why?
|
Radiology | 4 | 2020 | 2113 | 0.300 |
Why?
|
Chromomycin A3 | 1 | 2007 | 3 | 0.300 |
Why?
|
Societies, Medical | 10 | 2023 | 3905 | 0.300 |
Why?
|
Brachytherapy | 1 | 2015 | 1223 | 0.290 |
Why?
|
Vascular Diseases | 2 | 2019 | 1161 | 0.280 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2020 | 2297 | 0.270 |
Why?
|
Endovascular Procedures | 2 | 2019 | 2183 | 0.260 |
Why?
|
Pulmonary Veins | 2 | 2024 | 743 | 0.260 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2009 | 1136 | 0.260 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 1792 | 0.240 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2169 | 0.230 |
Why?
|
Splenic Artery | 1 | 2024 | 57 | 0.230 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2007 | 678 | 0.220 |
Why?
|
Radiology, Interventional | 2 | 2020 | 476 | 0.220 |
Why?
|
Blood Vessel Prosthesis | 2 | 2021 | 951 | 0.220 |
Why?
|
Image Enhancement | 1 | 2014 | 2885 | 0.220 |
Why?
|
Cytotoxins | 1 | 2004 | 153 | 0.220 |
Why?
|
Carcinoma, Renal Cell | 5 | 2011 | 3165 | 0.210 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7391 | 0.210 |
Why?
|
Quality Improvement | 2 | 2015 | 3801 | 0.210 |
Why?
|
Vena Cava, Inferior | 2 | 2016 | 458 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 4 | 2007 | 2803 | 0.200 |
Why?
|
Cell Hypoxia | 4 | 2007 | 656 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 988 | 0.190 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2004 | 220 | 0.190 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.190 |
Why?
|
Diagnostic Imaging | 6 | 2024 | 3530 | 0.190 |
Why?
|
Iodine | 1 | 2023 | 288 | 0.180 |
Why?
|
Neoplasms | 6 | 2024 | 22173 | 0.180 |
Why?
|
Aneurysm | 1 | 2024 | 337 | 0.180 |
Why?
|
Aneurysm, Infected | 1 | 2021 | 82 | 0.180 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.180 |
Why?
|
Arteriovenous Fistula | 1 | 2024 | 319 | 0.180 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2023 | 200 | 0.180 |
Why?
|
Catheters | 1 | 2023 | 427 | 0.180 |
Why?
|
Needles | 1 | 2023 | 451 | 0.170 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2020 | 189 | 0.170 |
Why?
|
Kidney Neoplasms | 4 | 2011 | 4251 | 0.170 |
Why?
|
Alloys | 1 | 2019 | 110 | 0.160 |
Why?
|
Microwaves | 1 | 2020 | 185 | 0.160 |
Why?
|
Venous Thrombosis | 2 | 2020 | 1303 | 0.160 |
Why?
|
Vasculitis | 2 | 2021 | 521 | 0.160 |
Why?
|
Oxygen | 7 | 2007 | 4227 | 0.150 |
Why?
|
Cell Death | 1 | 2004 | 1679 | 0.150 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2020 | 97 | 0.150 |
Why?
|
Polytetrafluoroethylene | 1 | 2019 | 245 | 0.150 |
Why?
|
Evidence-Based Medicine | 8 | 2023 | 3688 | 0.150 |
Why?
|
Hemophilia A | 1 | 2021 | 360 | 0.150 |
Why?
|
Thiazoles | 3 | 2010 | 1517 | 0.140 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 311 | 0.140 |
Why?
|
Iliac Artery | 1 | 2018 | 343 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2010 | 2226 | 0.140 |
Why?
|
Autophagy | 3 | 2010 | 1326 | 0.140 |
Why?
|
Quality Control | 1 | 2019 | 832 | 0.140 |
Why?
|
Radiology Department, Hospital | 1 | 2020 | 406 | 0.130 |
Why?
|
Drug Carriers | 1 | 2020 | 706 | 0.130 |
Why?
|
Energy Metabolism | 1 | 2007 | 2882 | 0.130 |
Why?
|
Ileal Diseases | 1 | 2016 | 68 | 0.130 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2017 | 128 | 0.130 |
Why?
|
Humans | 63 | 2024 | 761572 | 0.130 |
Why?
|
Uterine Artery Embolization | 1 | 2016 | 59 | 0.130 |
Why?
|
Prosthesis-Related Infections | 1 | 2021 | 487 | 0.130 |
Why?
|
Portal Vein | 2 | 2015 | 431 | 0.130 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2016 | 92 | 0.130 |
Why?
|
Waiting Lists | 1 | 2020 | 765 | 0.130 |
Why?
|
Uterine Diseases | 1 | 2016 | 108 | 0.120 |
Why?
|
Urinary Fistula | 1 | 2015 | 42 | 0.120 |
Why?
|
Intestinal Fistula | 1 | 2016 | 142 | 0.120 |
Why?
|
Workflow | 1 | 2020 | 851 | 0.120 |
Why?
|
Peripheral Vascular Diseases | 1 | 2018 | 488 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2021 | 735 | 0.120 |
Why?
|
Vascular Fistula | 1 | 2015 | 50 | 0.120 |
Why?
|
Fluoroscopy | 1 | 2019 | 947 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2004 | 2827 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 935 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 980 | 0.120 |
Why?
|
Extremities | 1 | 2019 | 867 | 0.110 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 95 | 0.110 |
Why?
|
Hepatic Encephalopathy | 1 | 2015 | 144 | 0.110 |
Why?
|
Vascular Malformations | 1 | 2019 | 468 | 0.110 |
Why?
|
Arterial Occlusive Diseases | 1 | 2018 | 748 | 0.110 |
Why?
|
Docosahexaenoic Acids | 1 | 2020 | 908 | 0.110 |
Why?
|
Mitochondria | 1 | 2007 | 3624 | 0.110 |
Why?
|
Practice Management, Medical | 1 | 2015 | 191 | 0.110 |
Why?
|
Sialoglycoproteins | 2 | 2005 | 315 | 0.110 |
Why?
|
Triage | 1 | 2020 | 986 | 0.110 |
Why?
|
Hypertension, Portal | 1 | 2015 | 226 | 0.110 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1457 | 0.100 |
Why?
|
Patient Care Planning | 1 | 2018 | 909 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 2016 | 432 | 0.100 |
Why?
|
Transcription Factors | 4 | 2005 | 12129 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1407 | 0.100 |
Why?
|
Prosthesis Implantation | 1 | 2016 | 592 | 0.100 |
Why?
|
Leiomyoma | 1 | 2016 | 636 | 0.090 |
Why?
|
Critical Pathways | 1 | 2015 | 474 | 0.090 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 186 | 0.090 |
Why?
|
Aorta | 1 | 2018 | 2041 | 0.090 |
Why?
|
United States | 13 | 2023 | 72335 | 0.090 |
Why?
|
Disease Progression | 3 | 2024 | 13510 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1202 | 0.090 |
Why?
|
Osteopontin | 3 | 2006 | 301 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1 | 2 | 2008 | 193 | 0.080 |
Why?
|
Luminescent Measurements | 2 | 2008 | 342 | 0.080 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2009 | 81 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2019 | 1265 | 0.080 |
Why?
|
von Hippel-Lindau Disease | 1 | 2010 | 151 | 0.080 |
Why?
|
Stents | 2 | 2024 | 3179 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
Luciferases, Firefly | 1 | 2008 | 37 | 0.080 |
Why?
|
Pyridines | 3 | 2010 | 2875 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2001 | 2917 | 0.080 |
Why?
|
Proline | 3 | 2008 | 457 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1866 | 0.080 |
Why?
|
Quinones | 2 | 1998 | 78 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2024 | 64684 | 0.070 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 16986 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9610 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1420 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2020 | 2751 | 0.070 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12975 | 0.070 |
Why?
|
Neovascularization, Pathologic | 2 | 2009 | 2644 | 0.070 |
Why?
|
Contrast Media | 4 | 2023 | 5311 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2019 | 2491 | 0.070 |
Why?
|
Tumor Cells, Cultured | 6 | 2004 | 6132 | 0.060 |
Why?
|
Male | 23 | 2024 | 360842 | 0.060 |
Why?
|
Antineoplastic Agents | 5 | 2011 | 13642 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2004 | 1899 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1656 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11121 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2015 | 1428 | 0.060 |
Why?
|
Female | 19 | 2024 | 392686 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 718 | 0.060 |
Why?
|
Phlebography | 2 | 2016 | 326 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 9002 | 0.060 |
Why?
|
Aniline Compounds | 1 | 2010 | 1069 | 0.060 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2004 | 37 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2024 | 80646 | 0.060 |
Why?
|
Neoplasms, Experimental | 1 | 2009 | 1229 | 0.060 |
Why?
|
Adult | 10 | 2024 | 221203 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2006 | 449 | 0.050 |
Why?
|
Middle Aged | 14 | 2024 | 220920 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2007 | 1529 | 0.050 |
Why?
|
Polyurethanes | 1 | 2024 | 109 | 0.050 |
Why?
|
Electric Power Supplies | 1 | 2023 | 96 | 0.050 |
Why?
|
Genes, ras | 1 | 2005 | 654 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58986 | 0.050 |
Why?
|
Animals | 18 | 2023 | 168467 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Head and Neck Neoplasms | 3 | 2006 | 2895 | 0.050 |
Why?
|
Blotting, Western | 2 | 2007 | 5035 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 318 | 0.050 |
Why?
|
Thrombin Time | 1 | 2021 | 7 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2008 | 8552 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2417 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2006 | 4026 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 6 | 2023 | 20571 | 0.050 |
Why?
|
Infusions, Intra-Arterial | 1 | 2020 | 221 | 0.040 |
Why?
|
Genes, Fungal | 1 | 2002 | 439 | 0.040 |
Why?
|
Hydroxylation | 3 | 2005 | 137 | 0.040 |
Why?
|
Time Factors | 6 | 2024 | 39970 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2024 | 767 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11122 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4793 | 0.040 |
Why?
|
Apoptosis | 4 | 2011 | 9489 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 348 | 0.040 |
Why?
|
Aged | 9 | 2024 | 169310 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1651 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2016 | 2115 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2005 | 1363 | 0.040 |
Why?
|
Young Adult | 4 | 2024 | 59255 | 0.040 |
Why?
|
Algorithms | 5 | 2023 | 14032 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 625 | 0.040 |
Why?
|
Cyclophilins | 1 | 1998 | 48 | 0.040 |
Why?
|
Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
Peptidylprolyl Isomerase | 1 | 1998 | 97 | 0.040 |
Why?
|
Models, Molecular | 2 | 2008 | 5439 | 0.040 |
Why?
|
Drainage | 1 | 2023 | 1157 | 0.040 |
Why?
|
Photons | 1 | 2021 | 589 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2004 | 5799 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2005 | 1745 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 642 | 0.040 |
Why?
|
Physical Examination | 1 | 2023 | 1255 | 0.040 |
Why?
|
Ultrasonography | 2 | 2023 | 5972 | 0.040 |
Why?
|
Edema | 1 | 2021 | 766 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4431 | 0.030 |
Why?
|
Palpation | 1 | 2017 | 166 | 0.030 |
Why?
|
Mice | 12 | 2009 | 81533 | 0.030 |
Why?
|
Enzyme Inhibitors | 2 | 1998 | 3713 | 0.030 |
Why?
|
Recurrence | 3 | 2018 | 8466 | 0.030 |
Why?
|
Sirolimus | 1 | 2004 | 1533 | 0.030 |
Why?
|
Rectum | 1 | 2021 | 892 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2264 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 529 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 598 | 0.030 |
Why?
|
Enoxaparin | 1 | 2019 | 391 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6766 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4465 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3778 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2007 | 7593 | 0.030 |
Why?
|
Protons | 1 | 2021 | 1116 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1998 | 397 | 0.030 |
Why?
|
Lactulose | 1 | 2015 | 31 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2385 | 0.030 |
Why?
|
Texas | 1 | 2016 | 404 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1154 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 1998 | 424 | 0.030 |
Why?
|
Hepatic Veins | 1 | 2015 | 112 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2898 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2021 | 1071 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2526 | 0.030 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 219 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 551 | 0.030 |
Why?
|
Trans-Activators | 1 | 2004 | 2856 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2644 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2015 | 335 | 0.030 |
Why?
|
Heparin | 1 | 2021 | 1634 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4063 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1997 | 666 | 0.030 |
Why?
|
Doxorubicin | 2 | 2017 | 2224 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10766 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2010 | 3076 | 0.030 |
Why?
|
Mice, SCID | 2 | 2009 | 2626 | 0.030 |
Why?
|
Swine | 1 | 2023 | 5915 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1773 | 0.030 |
Why?
|
Trauma Centers | 1 | 2019 | 937 | 0.030 |
Why?
|
Research | 1 | 2002 | 1982 | 0.030 |
Why?
|
Liver | 2 | 2020 | 7529 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1440 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2021 | 1661 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2015 | 537 | 0.030 |
Why?
|
Risk Factors | 4 | 2024 | 74213 | 0.030 |
Why?
|
Dactinomycin | 2 | 2005 | 304 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6815 | 0.030 |
Why?
|
Vascular Patency | 1 | 2015 | 911 | 0.020 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 537 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1611 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15266 | 0.020 |
Why?
|
Mice, Nude | 2 | 2008 | 3614 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1204 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3511 | 0.020 |
Why?
|
Hysterectomy | 1 | 2016 | 857 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2016 | 572 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12463 | 0.020 |
Why?
|
Thrombosis | 1 | 2024 | 2942 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1958 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6965 | 0.020 |
Why?
|
Mutation | 5 | 2008 | 30054 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
Rats | 3 | 2020 | 23741 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9177 | 0.020 |
Why?
|
Program Development | 1 | 2015 | 1297 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2242 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6032 | 0.020 |
Why?
|
Nanoparticles | 1 | 2020 | 1959 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1998 | 2448 | 0.020 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2009 | 149 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2006 | 5369 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2007 | 3603 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12059 | 0.020 |
Why?
|
Luciferases, Renilla | 1 | 2007 | 21 | 0.020 |
Why?
|
Transfection | 2 | 2008 | 5774 | 0.020 |
Why?
|
Vacuoles | 1 | 2008 | 228 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5247 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 3810 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 465 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9420 | 0.020 |
Why?
|
Yeasts | 1 | 2008 | 279 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3123 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2016 | 1489 | 0.020 |
Why?
|
Genes, p53 | 2 | 2001 | 712 | 0.020 |
Why?
|
Glycolysis | 1 | 2011 | 835 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2008 | 404 | 0.020 |
Why?
|
Benzoquinones | 2 | 1998 | 198 | 0.020 |
Why?
|
Thymidine Kinase | 1 | 2007 | 286 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2495 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2008 | 405 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2007 | 574 | 0.020 |
Why?
|
Connective Tissue Growth Factor | 1 | 2006 | 92 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 696 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5073 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2008 | 283 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1998 | 0.020 |
Why?
|
Lactams, Macrocyclic | 2 | 1998 | 318 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2018 | 15633 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 384 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2016 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 1989 | 0.020 |
Why?
|
Reoperation | 1 | 2015 | 4303 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1998 | 4937 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6484 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2007 | 837 | 0.010 |
Why?
|
Lysosomes | 1 | 2010 | 924 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14666 | 0.010 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2006 | 1060 | 0.010 |
Why?
|
Response Elements | 1 | 2005 | 309 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2004 | 283 | 0.010 |
Why?
|
Molecular Structure | 1 | 2008 | 1880 | 0.010 |
Why?
|
3T3 Cells | 1 | 2005 | 1085 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2008 | 2496 | 0.010 |
Why?
|
Cell Line | 3 | 2005 | 15601 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2005 | 12794 | 0.010 |
Why?
|
RNA Stability | 1 | 2005 | 329 | 0.010 |
Why?
|
Transcriptional Activation | 2 | 2001 | 1756 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 29629 | 0.010 |
Why?
|
Anticoagulants | 1 | 2019 | 4812 | 0.010 |
Why?
|
Cullin Proteins | 1 | 2004 | 179 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1076 | 0.010 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 2002 | 23 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23996 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1967 | 0.010 |
Why?
|
Cobalt | 1 | 2002 | 154 | 0.010 |
Why?
|
Deferoxamine | 1 | 2002 | 155 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1509 | 0.010 |
Why?
|
Ligases | 1 | 2003 | 333 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36429 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3597 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1545 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9319 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2004 | 624 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 4513 | 0.010 |
Why?
|
Databases as Topic | 1 | 2003 | 473 | 0.010 |
Why?
|
Chelating Agents | 1 | 2002 | 387 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
NF-kappa B | 1 | 2009 | 2490 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21355 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2006 | 1264 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3849 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3733 | 0.010 |
Why?
|
Glucose | 1 | 2011 | 4346 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 88324 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1903 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1646 | 0.010 |
Why?
|
Ubiquitin | 1 | 2004 | 839 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2865 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2005 | 14416 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2001 | 368 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3792 | 0.010 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 110 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5791 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2006 | 2915 | 0.010 |
Why?
|
Acetylation | 1 | 2001 | 1055 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1998 | 237 | 0.010 |
Why?
|
Intramolecular Oxidoreductases | 1 | 1998 | 105 | 0.010 |
Why?
|
Octoxynol | 1 | 1997 | 77 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6374 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2004 | 1120 | 0.010 |
Why?
|
Leupeptins | 1 | 1997 | 113 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1997 | 189 | 0.010 |
Why?
|
Cycloheximide | 1 | 1997 | 343 | 0.010 |
Why?
|
Gamma Rays | 1 | 1998 | 318 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1998 | 522 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1997 | 188 | 0.010 |
Why?
|
Detergents | 1 | 1997 | 236 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2192 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2005 | 2456 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 11904 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2009 | 3548 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2001 | 720 | 0.010 |
Why?
|
Half-Life | 1 | 1997 | 651 | 0.010 |
Why?
|
Protein Conformation | 1 | 2004 | 3968 | 0.010 |
Why?
|
Growth Substances | 1 | 1998 | 768 | 0.010 |
Why?
|
Acetylcysteine | 1 | 1997 | 260 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2001 | 774 | 0.010 |
Why?
|
Ubiquitins | 1 | 1997 | 366 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54426 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3617 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2002 | 1742 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3430 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2005 | 3113 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2001 | 2707 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41493 | 0.010 |
Why?
|
Iron | 1 | 2002 | 1793 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2872 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 18965 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 1998 | 754 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3323 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3449 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10448 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13446 | 0.010 |
Why?
|
Cisplatin | 1 | 1998 | 1652 | 0.010 |
Why?
|
Binding Sites | 1 | 2001 | 6056 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2910 | 0.010 |
Why?
|
Fibroblasts | 1 | 2002 | 4141 | 0.010 |
Why?
|
Lymphoma | 1 | 2001 | 1901 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1997 | 1189 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17635 | 0.010 |
Why?
|
DNA Damage | 1 | 2001 | 2449 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2002 | 2688 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1997 | 1321 | 0.010 |
Why?
|
Protein Binding | 1 | 2002 | 9353 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8321 | 0.010 |
Why?
|
Computational Biology | 1 | 2002 | 3517 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20099 | 0.010 |
Why?
|
Internet | 1 | 2001 | 3093 | 0.000 |
Why?
|
Software | 1 | 2001 | 4434 | 0.000 |
Why?
|
Gene Expression | 1 | 1998 | 7581 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9469 | 0.000 |
Why?
|
Signal Transduction | 1 | 2001 | 23447 | 0.000 |
Why?
|